Publications of Dr. Terhune


NCBI PubMed search

  1. Terhune SS, Schroer J, Shenk T.
    RNAs are packaged into human cytomegalovirus virions in proportion to their
    intracellular concentration.
    J Virol. 2004 Oct;78(19):10390-8.
  2. Goodrum F, Jordan CT, Terhune SS, High K, Shenk T.
    Differential outcomes of human cytomegalovirus infection in primitive
    hematopoietic cell subpopulations.
    Blood. 2004 Aug 1;104(3):687-95. Epub 2004 Apr 13.
  3. Terhune SS, Hubert WG, Thomas JT, Laimins LA.
    Early polyadenylation signals of human papillomavirus type 31 negatively regulate
    capsid gene expression.
    J Virol. 2001 Sep;75(17):8147-57.
  4. Thomas JT, Oh ST, Terhune SS, Laimins LA.
    Cellular changes induced by low-risk human papillomavirus type 11 in
    keratinocytes that stably maintain viral episomes.
    J Virol. 2001 Aug;75(16):7564-71.
  5. Terhune SS, Milcarek C, Laimins LA.
    Regulation of human papillomavirus type 31 polyadenylation during the
    differentiation-dependent life cycle.
    J Virol. 1999 Sep;73(9):7185-92.
  6. Terhune SS, Coleman KT, Sekulovich R, Burke RL, Spear PG.
    Limited variability of glycoprotein gene sequences and neutralizing targets in
    herpes simplex virus type 2 isolates and stability on passage in cell culture.
    J Infect Dis. 1998 Jul;178(1):8-15.
  7. Dean HJ, Warner MS, Terhune SS, Johnson RM, Spear PG.
    Viral determinants of the variable sensitivity of herpes simplex virus strains to
    gD-mediated interference.
    J Virol. 1995 Aug;69(8):5171-6.
  8. Dean HJ, Terhune SS, Shieh MT, Susmarski N, Spear PG.
    Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance
    to gD-mediated interference and cause cell-type-dependent alterations in
    infectivity.
    Virology. 1994 Feb 15;199(1):67-80.